Drug Makers Duke It Out Over Smallpox Vaccine Patent
The U.S. government's desire to protect citizens from a biological terrorist attack has triggered patent litigation between two European drug makers, both leading producers of smallpox vaccinations....To view the full article, register now.
Already a subscriber? Click here to view full article